top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

5.080 -0.110 (-2.12%)
Streaming Delayed Price Updated: 9:54 AM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside
Via AB Newswire
News headline image
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Reversal Alert: VTIX, MARA, IBRX, BATL, NDRA, EEIQ Gain Momentum as Multi-Sector Catalysts Build
Via AB Newswire
News headline image
Speculation Alert: PRSO, ITOC, NDRA, BZAI Small-Cap Momentum Builds – More Names Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks Under $10: IBRX, VTIX, NDRA, SMX – 2026 Watch Now!
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): Medical Diagnostic Play in the $100B+MASH+GLP-1 Healthcare Boom
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
Via AB Newswire
News headline image
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA)
Via Get News
News headline image
NASDAQ March 2026: VTIX, ONDS, RUBI, NDRA, SOUN + Others – February’s Most Shorted Names Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
Stocks in the News: ALBT, NDRA, CURX, HCTI – AI, Clinical Milestones Drive Market Surges
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
ENDRA Life Sciences (NASDAQ: NDRA): A Dual-Engine Growth Story Alongside KNRX, BATL, TALK, DNN, VZLA in Focus
Via AB Newswire
News headline image
5 Stocks Under $5 to Watch Now: OBAI, NDRA, RIME, VTIX, OPEN
Via AB Newswire
Topics Artificial Intelligence Economy
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Gaining Attention as HYPE Token Surges See Why Now! FEED, SER, TRX, XHLD, BATL Inside
Via AB Newswire
Topics Derivatives
News headline image
$5 Stocks: NDRA, IBRX, MOVE, RVLY Drawing Attention Watch Now!
Via AB Newswire
News headline image
MAGA SmallCaps Watchlist: ROLR, SURG, IBRX, BNAI, NDRA – January 2026 Focus
Via AB Newswire
Topics Derivatives
News headline image
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
Via AB Newswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
Via AB Newswire
News headline image
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential
Via AB Newswire
Topics Artificial Intelligence Death
News headline image
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform
Via AB Newswire
News headline image
Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside
Via AB Newswire
Topics Artificial Intelligence Economy Intellectual Property
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology
Via AB Newswire
News headline image
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare
Via AB Newswire
News headline image
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
From ENDRA Life Sciences Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page